Medprin Regenerative Medical Technologies Co., Ltd.

SZSE:301033 Stock Report

Market Cap: CN¥3.5b

Medprin Regenerative Medical Technologies Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Jianhua Wang

Chief executive officer

CN¥1.3m

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.01%
Management average tenureno data
Board average tenure1.5yrs

Recent management updates

Recent updates

Medprin Regenerative Medical Technologies Co., Ltd. (SZSE:301033) Looks Just Right With A 38% Price Jump

May 08
Medprin Regenerative Medical Technologies Co., Ltd. (SZSE:301033) Looks Just Right With A 38% Price Jump

CEO

Jianhua Wang (56 yo)

less than a year

Tenure

CN¥1,318,900

Compensation

Mr. Jianhua Wang is Director of Medprin Regenerative Medical Technologies Co. Ltd. from May 18, 2023 and serves as General Manager since April 17, 2024 and was its Deputy General Manager until April 17, 20...


Board Members

NamePositionTenureCompensationOwnership
Jianhua Wang
GM & Director1.5yrsCN¥1.32m0.011%
CN¥ 401.1k
Yahong Luo
CFO, Deputy GM & Non-Independent Directorno dataCN¥759.40k0.059%
CN¥ 2.1m
Xiaoyan Long
Board Secretary & Non-Independent Director2.6yrsCN¥574.80k0.012%
CN¥ 417.1k
Xiaoming Chen
Independent Directorless than a yearno datano data
Jianhua Chen
Independent Directorless than a yearno datano data
Meifu Yuan
Non-Independent Directorno datano data4.4%
CN¥ 153.4m
Yuyu Yuan
Chairman of the Boardno dataCN¥772.50k16.63%
CN¥ 580.0m
Haiying Zheng
Directorno datano datano data
Meiling Mo
Supervisorno datano datano data
Xian Zhuang
Chairman of the Supervisory Board1.6yrsno datano data
Qing Yuan
Independent Directorless than a yearno datano data
Jinmei Liang
Supervisor1.5yrsno datano data

1.5yrs

Average Tenure

44yo

Average Age

Experienced Board: 301033's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.